ALLEGRO OPHTHALMICS
Allegro Ophthalmics is a late-stage ophthalmic biopharmaceutical company focused on redefining the retina space with integrin inhibition therapy, a potential market-disrupting class of drugs for the treatment of retinal diseases. Allegro’s lead investigational drug, risuteganib (Luminate), a broad-spectrum integrin inhibitor, downregulates oxidative stress upstream, at its source, simultaneously affecting all four pathways of oxidative stress that contribute to retinal diseases such as diabeti... c macular edema (DME) and nonexudative age-related macular degeneration (dry AMD). Risuteganib has successfully met the endpoints for three Phase 2 studies and is preparing to enter Phase 3 studies in DME during the first half of 2019. In addition, risuteganib is being studied in a Phase 2 trial for the treatment of dry AMD with topline results anticipated in Q3 2019. Allegro is working closely with the global retina community to bring to market new treatment options for leading causes of blindness and is committed to offering patients an improved quality of life sustained by self-sufficient, functional vision.
ALLEGRO OPHTHALMICS
Industry:
Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
San Juan Capistrano, California, United States
Country:
United States
Website Url:
http://www.allegroeye.com
Total Employee:
11+
Status:
Active
Contact:
+9499408130
Email Addresses:
[email protected]
Total Funding:
42.7 M USD
Technology used in webpage:
Domain Not Resolving Person Schema Gravatar Profiles U.S. Server Location
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Viatris
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hanmi Pharmaceutical
Hanmi Pharmaceutical investment in Series C - Allegro Ophthalmics
Official Site Inspections
http://www.allegroeye.com Semrush global rank: 5.44 M Semrush visits lastest month: 1.37 K
- Host name: 137.68.167.72.host.secureserver.net
- IP address: 72.167.68.137
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Allegro Ophthalmics"
About Us - Allegro Ophthalmics - From Theory to Therapy
Allegro Ophthalmics is establishing integrin peptide therapy as the next-generation pharmaceutical category for the treatment of neovascular retinal diseases. Our lead …See details»
Management Team - Allegroeye
The commercial success of any therapy depends not just on the science but on the people who bring these innovative treatments to market. Our talented, passionate management team holds years of experience in building …See details»
Allegro Ophthalmics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +9499408130 Allegro Ophthalmics is a late-stage ophthalmic biopharmaceutical company focused on redefining the retina space with integrin inhibition therapy, a potential market …See details»
Allegro Ophthalmics, LLC | LinkedIn
Allegro Ophthalmics, LLC is a late-stage ophthalmic biopharmaceutical company focused on redefining the retina space with integrin inhibition therapy, a potential market-disrupting class …See details»
Allegro Ophthalmics Company Profile 2025: Valuation, Funding ...
Www.allegroeye.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 31473 Rancho Viejo Road; Suite 204; San Juan …See details»
Allegro Ophthalmics - Overview, News & Similar companies
Allegro Ophthalmics contact info: Phone number: (949) 940-8130 Website: www.allegroeye.com What does Allegro Ophthalmics do? Allegro Ophthalmics, LLC is a privately held …See details»
Allegro Ophthalmics, LLC Overview | SignalHire Company Profile
Phone Number: 1-949-940-8130: Allegro Ophthalmics,... industries Pharma, Pharmaceuticals, BiotechnologySee details»
Allegro Ophthalmics, LLC Information - RocketReach
Allegroeye.com; 2 949235XXXX; 949489XXXX; John Park Co-Founder and Vice President at Allegro Ophthalmics, LLC Santa Ana, CA, US View. 1 949940XXXX; Melvin Sarayba Vice …See details»
Allegro Ophthalmics - Craft
Allegro Ophthalmics has 5 employees at their 1 location and $42.7 m in total funding,. See insights on Allegro Ophthalmics including office locations, competitors, revenue, financials, …See details»
Company - Allegro Ophthalmics - From Theory to Therapy
Apr 13, 2023 We’re bringing innovation to the eye care space with a novel mitochondrial stabilizer therapy, a new class of drugs for the treatment of ocular diseases. Risuteganib …See details»
Allegro Ophthalmics - VentureRadar
Similar Companies: Formosa Pharmaceuticals Taiwan n/a Formosa Pharmaceuticals is a Taiwan-based biotech with primary focus in the areas of ophthalmology and oncology, and global …See details»
Allegro Ophthalmics LLC Overview - Salary.com
Discover essential details about Allegro Ophthalmics LLC, including address, contact, and journey of our company's evolution.See details»
Allegro Ophthalmics CEO and key executive team | Craft.co
Allegro Ophthalmics's CEO is Vicken Karageozian. Other executives include William J. Link, Chairman; Hampar Karageozian, CTO and 3 others. See the full leadership team at Craft.See details»
Allegro Ophthalmics Company Profile: Overview and Full News …
Allegroeye.com. Overview: Allegro Ophthalmics. Allegro Ophthalmics, based in California, is a company dedicated to redefining the treatment of ocular diseases by focusing on improving …See details»
Allegro Ophthalmics LLC (Allegro Ophthalmics LLC) - 药物管线_专 …
- Intermediate Dry AMD Treatment Is a Significant Unmet Need - Mitochondrial Stabilizing Candidate Risuteganib Has Shown Best Corrected Visual Acuity Gains in Dry AMD Patient …See details»
Management Team - Allegro Ophthalmics - From Theory to Therapy
The commercial success of any therapy depends not just on the science but on the people who bring these innovative treatments to market. Our talented, passionate management team …See details»
Bausch Health To Acquire Option To Purchase All Ophthalmology …
Sep 21, 2020 For more information, visit www.allegroeye.com. About Bausch + Lomb Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely …See details»
Pipeline - Allegro Ophthalmics - From Theory to Therapy
Apr 13, 2023 Email: [email protected]. RECENT NEWS. Allegro Ophthalmics Licensee AffaMed Therapeutics Receives Phase 3 CTA Approval in China for Risuteganib for the …See details»
Science - Allegro Ophthalmics - From Theory to Therapy
Apr 23, 2019 Channeling the potential of mitochondrial stabilizer therapy Tapping into multiple pathways of mitochondrial dysfunction and oxidative stress in ophthalmology Neovascular …See details»